Kaspar M - Search Results

1

Engineered vascular-targeting antibody-interferon-gamma fusion protein for cancer therapy.

Ebbinghaus C, Ronca R, Kaspar M, Grabulovski D, Berndt A, Kosmehl H, Zardi L, Neri D. Ebbinghaus C, et al. Among authors: kaspar m. Int J Cancer. 2005 Aug 20;116(2):304-13. doi: 10.1002/ijc.20952. Int J Cancer. 2005. PMID: 15800913

2

Fibronectin as target for tumor therapy.

Kaspar M, Zardi L, Neri D. Kaspar M, et al. Int J Cancer. 2006 Mar 15;118(6):1331-9. doi: 10.1002/ijc.21677. Int J Cancer. 2006. PMID: 16381025 Review.

3

The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis.

Kaspar M, Trachsel E, Neri D. Kaspar M, et al. Cancer Res. 2007 May 15;67(10):4940-8. doi: 10.1158/0008-5472.CAN-07-0283. Cancer Res. 2007. PMID: 17510424

4

A novel, non-immunogenic Fyn SH3-derived binding protein with tumor vascular targeting properties.

Grabulovski D, Kaspar M, Neri D. Grabulovski D, et al. Among authors: kaspar m. J Biol Chem. 2007 Feb 2;282(5):3196-204. doi: 10.1074/jbc.M609211200. Epub 2006 Nov 27. J Biol Chem. 2007. PMID: 17130124 Free article.

5

Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis.

Trachsel E, Bootz F, Silacci M, Kaspar M, Kosmehl H, Neri D. Trachsel E, et al. Among authors: kaspar m. Arthritis Res Ther. 2007;9(1):R9. doi: 10.1186/ar2115. Arthritis Res Ther. 2007. PMID: 17261171 Free PMC article.

6

The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases.

Rybak JN, Roesli C, Kaspar M, Villa A, Neri D. Rybak JN, et al. Among authors: kaspar m. Cancer Res. 2007 Nov 15;67(22):10948-57. doi: 10.1158/0008-5472.CAN-07-1436. Cancer Res. 2007. PMID: 18006840

7

A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo.

Villa A, Trachsel E, Kaspar M, Schliemann C, Sommavilla R, Rybak JN, Rösli C, Borsi L, Neri D. Villa A, et al. Among authors: kaspar m. Int J Cancer. 2008 Jun 1;122(11):2405-13. doi: 10.1002/ijc.23408. Int J Cancer. 2008. PMID: 18271006

8

Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy.

Mårlind J, Kaspar M, Trachsel E, Sommavilla R, Hindle S, Bacci C, Giovannoni L, Neri D. Mårlind J, et al. Among authors: kaspar m. Clin Cancer Res. 2008 Oct 15;14(20):6515-24. doi: 10.1158/1078-0432.CCR-07-5041. Clin Cancer Res. 2008. PMID: 18927291

9

A human mAb specific to oncofetal fibronectin selectively targets chronic skin inflammation in vivo.

Trachsel E, Kaspar M, Bootz F, Detmar M, Neri D. Trachsel E, et al. Among authors: kaspar m. J Invest Dermatol. 2007 Apr;127(4):881-6. doi: 10.1038/sj.jid.5700653. Epub 2006 Dec 21. J Invest Dermatol. 2007. PMID: 17185984 Free article.

10

Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.

Schliemann C, Palumbo A, Zuberbühler K, Villa A, Kaspar M, Trachsel E, Klapper W, Menssen HD, Neri D. Schliemann C, et al. Among authors: kaspar m. Blood. 2009 Mar 5;113(10):2275-83. doi: 10.1182/blood-2008-05-160747. Epub 2008 Nov 12. Blood. 2009. PMID: 19005180 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters